Skp2: a dream target in the coming age of cancer therapy.
about
Targeting the ubiquitin pathway for cancer treatmentPosttranslational regulation of Akt in human cancerNOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancerCurcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cellsSkp2 is over-expressed in breast cancer and promotes breast cancer cell proliferationTargeting ubiquitination for cancer therapies.Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells.Matrine derivative YF-18 inhibits lung cancer cell proliferation and migration through down-regulating Skp2.Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing TwistPaeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells.The steady-state level of CDK4 protein is regulated by antagonistic actions between PAQR4 and SKP2 and involved in tumorigenesis.Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells.Genistein inhibits the S-phase kinase-associated protein 2 expression in breast cancer cells.S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.
P2860
Q26866185-E1CD6D03-1284-4E83-95E6-D9569954511DQ27027815-549D1248-CE77-4DB9-A515-3DD58372854DQ30276974-6ADBC731-0429-45E1-8176-EBA017ACBFC8Q33602815-E3280093-78FB-4DB4-8D09-B58AB4B2968DQ35380380-E442DE4F-7BA1-4F6B-8320-77D07FE7B736Q36021953-80C7BDE8-B71D-49F0-9CE3-3249057E99D0Q36228504-605D920E-50A2-4DBA-A0F3-768A3BDC2857Q36956900-35081C59-5FB0-48FE-A5F5-AAB60444C039Q37158445-67B2631D-033D-4D82-B486-FAB0E7E9F751Q37687014-8FFFBB08-5816-4E51-A31E-24C9C864F735Q37706977-17686260-3D7D-4BD4-97A2-7517851C476CQ41686942-732A383D-7A91-46AA-AE7A-9F9A6F92DDA7Q47246307-378CD16A-1FEC-4862-AF88-61D66199251FQ47676519-932C84DC-3652-475C-BE17-E9DBF61BCA87Q48771383-BC708247-DD99-451E-9EFD-C35CCA2D3C36Q49444302-87114794-6732-4674-B2FA-61EF44154160Q52605294-D6272995-F1D9-4702-8C41-D3ABED07ED57
P2860
Skp2: a dream target in the coming age of cancer therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Skp2: a dream target in the coming age of cancer therapy.
@en
Skp2: a dream target in the coming age of cancer therapy.
@nl
type
label
Skp2: a dream target in the coming age of cancer therapy.
@en
Skp2: a dream target in the coming age of cancer therapy.
@nl
prefLabel
Skp2: a dream target in the coming age of cancer therapy.
@en
Skp2: a dream target in the coming age of cancer therapy.
@nl
P2860
P356
P1433
P1476
Skp2: a dream target in the coming age of cancer therapy
@en
P2093
Hui-Kuan Lin
Shuxing Zhang
P2860
P304
P356
10.4161/CC.27853
P577
2014-01-21T00:00:00Z